Evidence map›Paper›PMID 25598583›Full record

ArticleTetrahedron, asymmetry2006

Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries. Part 3.

Ke Huang, Zachary S Breitbach, Daniel W Armstrong

Abstract read
In one paragraph

Article in Tetrahedron, asymmetry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 31 citations in OpenAlex.

  1. Fast, sensitive LC-MS resolution ofAnalytical and bioanalytical chemistry · 2024
    Article
  2. Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2022
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ke HuangDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019, USA.
Zachary S BreitbachDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019, USA.
Daniel W ArmstrongDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76019, USA.
The University of Texas at Arlington · US

Funding

CHIRAL RECOGNITION BY MACROCYCLIC GLYCOPEPTIDESR01GM053825 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI ARMSTRONG, DANIEL W. · 1996 to 2008
$1.8M
NIGMS NIH HHS R01 GM053825
6 · The paper itself

Abstract

The enantiomeric excess of chiral reagents used in asymmetric syntheses directly affects the reaction selectivity and product purity. In this work, 84 of the more recently available chiral compounds were evaluated to determine their actual enantiomeric composition. These compounds are widely used in asymmetric syntheses as chiral synthons, catalysts, and auxiliaries. These include chiral alcohols, amines, amino alcohols, amides, carboxylic acids, epoxides, esters, ketones, and oxolanes among other classes of compounds. All enantiomeric test results were categorized within five purity levels (i.e. <0.01%, 0.01% to 0.1%, 0.1% to 1%, 1% to 10%, and >10%). The majority of the reagents tested were determined to have enantiomeric impurities over 0.01%, and two of them were found to contain enantiomeric impurities exceeding the 10% level. The most effective enantioselective analysis method was a GC approach using a Chiraldex GTA chiral stationary phase (CSP). This method worked exceedingly well with chiral amines and alcohols.

Identifiers

PMID25598583
PMCPMC4294700
OpenAlexW1985134734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.